A number of protein toxins bind at the surface of mammalian cells and after endocytosis traffic to the endoplasmic reticulum, where the toxic A chains are liberated from the holotoxin.
The endoplasmic reticulum (ER) lumen is the site of entry, via the Sec61associated translocon, of nascent unfolded proteins destined for the secretory pathway or for insertion into the ER membrane. Once inside the ER, these proteins fold and mature. This may require core N-glycosylation, disulphide bond formation and oligomerisation. These processes are overseen by ER quality control surveillance which may involve a combination of retrieval from post-ER compartments, ER retention, autophagy and/or ER associated protein degradation (ERAD) mechanisms (Ellgaard et al. 1999) .
ERAD comprises multiple disposal processes that recognise terminally misfolded, unwanted and orphan proteins and remove them from the ER by directing them to the cytosolic proteasomes for their destruction . Recognition occurs via scrutiny of N-glycosylation status (Jakob et al. 1998) and by ER chaperones ) which identify misfolded and unassembled proteins, and maintain their solubility before removal. Removal (or dislocation) requires membrane-integral ubiquitin ligase complexes that normally polyubiquitylate the target ERAD substrates as they are extruded through the 'dislocon' to enter the cytosol (Carvalho et al. 2006; Denic et al. 2006 ).
Polyubiquitylation provides tags both for the AAA-ATPase Cdc48p complex which acts as a cytosolic extraction motor (Bays et al. 2001; Jarosch et al. 2002; Rabinovich et al. 2002; Ye et al. 2001 ) and for subsequent interactions with the proteasome (Elkabetz et al. 2004; Lipson et al. 2008) . Typically, dislocated proteins are deglycosylated if required, de-ubiquitylated and destroyed by proteasomal degradation (Vembar and Brodsky 2008) .
A number of proteins are thought to utilise ERAD components to gain cytosolic access, but uncouple from the final destructive steps of ERAD. The best characterised of these are the catalytically active A chains of some plant and bacterial AB toxins which bind cell surface components and are endocytosed, subsequently trafficking to the ER lumen where the toxic A and cell-binding B chain(s) are separated. The A chains are then unfolded to cross the ER membrane, subsequently folding to a catalytic conformation to modify their cytosolic targets (Spooner et al. 2006 ). The yeast viral AB toxin K28 also dislocates from the ER and its A chain recovers catalytic activity in the cytosol (Heiligenstein et al. 2006) . Similarly, the human hepatitis E virus ORF2 protein which is initially inserted into the ER lumen subsequently accumulates in the cytosol of infected cells (Surjit et al. 2007 ).
This phenomenon of ERAD-like dislocation and subsequent folding in the cytosol extends beyond cytotoxic and viral proteins. Both firefly and Renilla luciferases are taken up macropinocytotically by dendritic cells and are then thought to be trafficked in vesicular structures to the ER, where they unfold to utilise ERAD components, subsequently refolding in the cytosol (Giodini and Cresswell 2008) . In addition, calreticulin, a protein that is normally regarded as an ER resident, has been identified in mammalian cytosolic extracts where it appears to have a role in integrin binding. This cytosolic pool of calreticulin is derived from an ER population and so has presumably been dislocated in an ERAD-like manner and then been refolded in the cytosol rather than being destroyed (Afshar et al. 2005) . Thus an uncoupling from the final destructive stages of ERAD may be a fundamental cellular pathway for which, to date, only a few substrates have been identified. Seen in this light, ERAD pathways may be described as a sub-set of ER dislocation events that results in the destruction of the dislocating protein.
The protein toxins that utilise ERAD pathway components for cytosolic entry provide toxic probes to test for both dislocation requirements and also the processes that are required for recovery of catalytic activity in the cytosol. Here we consider mainly the ER-trafficking ricin and Shiga toxins, but research on these has not followed parallel paths. Recent research has provided substantial detail about dislocation of ricin, but details of its trafficking are sparse. In contrast, much is known about Shiga toxin trafficking, but less about the processes of its dislocation. We therefore also consider cholera toxin, which bears a superficial resemblance in structural terms to Shiga toxin. We discuss here how the use of dislocating toxins reveals not only how the individual toxin A chains themselves breach the ER membrane and regain activity, but also describes features of a fundamental cell transport process.
Toxin Structure and Function

2.1
Ricin
The AB toxin ricin ( Figure 1) is produced in the developing endosperm of the seeds of the castor oil plant, Ricinus communis (Harley and Beevers 1986) , as a preproprotein that is matured by proteolytic cleavage. The mature heterodimeric holotoxin comprises a catalytically active A chain (RTA) disulphide-linked to a lectin B chain (RTB). RTA is an RNA N-glycosidase that targets the large ribosomal subunits, depurinating them by removing one specific adenyl residue from the site of interaction of elongation factors, thus halting protein synthesis . Since ricin maturation occurs within vacuoles derived from protein bodies of the endosperm then the host plant protein synthesis is protected from the depurination activity during germination of castor beans (Harley and Beevers 1982) . Ricin B chain (RTB) binds terminal non-reducing galactose residues (exposed β1→4 linked galactosyls) on cell surface proteins and lipids (Olsnes et al. 1974) . Whilst Nglycosylated proteins have been proposed to act as the sole potential receptors for ricin toxicity (Spilsberg et al. 2003) , mammalian cells with mutant Nacetylglucosaminyl transferase 1 are unable to synthesise complex N-glycans on target proteins (Reeves et al. 2002 ) and yet are only protected from a ricin challenge by a factor of 20-fold (Crispin et al. 2009 ). This suggests that~5% of productive receptors (those whose binding results in cytotoxicicity) are non-protein, and are presumably glycolipid. To date, no definitive receptors have been identified.
2.2
Shiga Toxin and Cholera Toxin
Shiga toxin (STx) is synthesised by the bacterium Shigella, and the closely related Shiga-like toxins by enterohemorrhagic strains of E. coli. All comprise an A1-A2 chain which is tightly associated with a doughnut-shaped ring of 5 B-chain subunits ( Figure 1 ). Cleavage by furin in the early stages of target mammalian cell intracellular transport results in an activated A1 chain disulphide linked to the A2 chain (Garred et al. 1995) . It is the STxA1 chain that subsequently dislocates (LaPointe et al. 2005) .
Like RTA, STxA1 also depurinates the large ribosomal subunit, in a catalytically identical process (Endo et al. 1988) . Each STxB chain subunit can bind 3 molecules of its receptor, the glycolipid globotriaosylceramide or Gb3 (Jacewicz et al. 1989 ).
Upon cell-surface Gb3 binding extensive cross-linking of receptor forces a reorganization of the lipid membrane, a cargo-induced promotion of membrane curvature and invagination (Römer et al. 2007; Windschiegl et al. 2009 ).
Superficially similar in structure to STx is cholera toxin (CTx), produced by the bacterium Vibrio cholera (Figure 1 ). It also has an activated A1 chain, disulphide linked to an A2 chain that remains tightly associated with a pentameric ring of B subunits. Activation, though, is by the metalloproteinase ADAM-17, rather than by furin (Valeva et al. 2004) , and the A1 chain stimulates adenyl cyclase, which increases cyclic AMP concentrations in the cytosol and results in massive secretory diarrhoea (Sharp and Hynie 1971) . The CTxB subunits can each bind 3 molecules of its lipid receptor GM1 with a similar geometry to STxB/Gb3 binding (Heyningen 1974) , an energetically stable clustering that allows STxB and polyoma family viruses to induce membrane invaginations (Ewers et al. 2010) .
Toxin Intracellular Trafficking to the Endoplasmic Reticulum (ER)
The three toxins considered here all bind their respective receptors at the plasma membrane and are internalised endocytotically, trafficking via early endosomes, the trans-Golgi network and the Golgi stack to the ER lumen ( Figure 2 and Golgi passage.
Although early observations concluded that STx and CTx traffic indistinguishably to the Golgi complex (Nichols et al. 2001) , it has become clear that these pathways can be separated at the endosomal level by use of the small molecule Exo2, an inhibitor of a sub-set of Arf-GEF functions ) which strongly blocks egress of STx from the early endosomes (Spooner et al. 2008b ) but which has little or no effect on CTx trafficking (Feng et al. 2004 ). Furthermore, the clathrin associated Hcs70 cochaperone RME-8 regulates endosomal trafficking of STx (Popoff et al. 2009 ) whilst having no effect on the transport of cholera toxin (Girard et al. 2005) .
The role of the Golgi stack is not clear, since all three toxins negotiate this without using the COPI-dependent route that characterises retrograde Golgi transport. Golgi functions are essential, at least for STx, since subcellular surgery to remove the Golgi stack halts the toxin retrograde transport process (McKenzie et al. 2009 ). Nevertheless, a discrete Golgi stack is not necessary, since a derivative of Exo2 that fuses Golgi and ER membranes and disrupts the remaining Golgi into small punctae has no measurable effect on STx toxicity ).
It appears that whilst all three toxins traffic from early endosomes to the trans-Golgi network and through the Golgi stack, the routes taken are idiosyncratic. Nevertheless the terminal destination of holotoxin is the ER lumen (Rapak et al. 1997; Sandvig et al. 1994; Wales et al. 1992 ).
ER Pre-dislocation Events
ERAD substrates are recognised as terminally unfolded and then dispatched to the cytosol for destruction. However, ER-trafficking toxins arrive in the ER as fullyfolded stable molecules and are thus very poor substrates for dislocation processes.
The key to their toxicity, then, lies in destabilisation of the toxins upon ER luminal arrival by reductive separation of the catalytic A or A1 chains from their ER-targeting B chains, followed by unfolding and recognition as substrates for dislocation.
4.1
Reductive Separation of the Holotoxin Subunits
In the absence of heat and denaturant, high concentrations of the small molecule reducing agent DTT are required to separate the RTA and RTB chains of ricin in vitro (Emmanuel et al. 1988; Simpson et al. 1995c ): thus the disulphide bridge connecting these chains is occluded, and separation would normally require a remodelling of the holotoxin structure to open the interface between RTA and RTB and allow reductive cleavage. Protein disulphide isomerase (PDI) possesses the qualities required, since it acts both as a protein-binding chaperone and as a disulphide exchanger (Ferrari and Söling 1999; Klappa et al. 1997) . Upon separation of the A and B chains, the nearest RTA binding partner with an available oxidisable cysteine would be its erstwhile RTB partner ( Figure 2 ). Thus, overexpression of RTB at the site of reduction should protect cells from ricin by acting as a dead-end receptor for newly-released RTA. Expression of RTB in the mammalian ER has precisely this effect (Spooner et al. 2004 (Majoul et al. 1996 ) -showed that for CTx, the bridge between the A1 and A2 chains is sensitive to the ratio of oxidised and reduced glutathione in the ER and that ER-lumenal PDI is required for the acceleration of the reduction of CTxA1 and A2 (Majoul et al. 1997; Orlandi 1997) .
4.2
Unfolding of the Toxin A Chains
Comparison of crystal structures of ricin and RTA reveals that RTA takes up different stable conformations depending upon whether it is part of holotoxin or not. Thus reductive separation of RTA and RTB results in a general re-modelling of RTA, a specific displacement of its C-terminal tail (Figure 3 , cyan) and the exposure of a relatively hydrophobic patch that had previously been occluded by RTB (Figure 3 , blue). A number of mutations in this region have no major effect on catalytic activity of RTA in vitro, nor on in vitro re-association of recombinant RTA with wild-type RTB, and yet the reassociated holotoxins display reduced toxicity (Simpson et al. 1995b) . Similarly, adding charged residues at the C-terminus of RTA hinders toxicity without obvious effects on catalytic activity or subunit re-association/dissociation (Simpson et al. 1995c ).
Taken together, these results implicate the hydrophobic stretch as important for membrane translocation, suggesting that this region interacts with the ER membrane prior to RTA dislocation. Supporting this interpretation is the partitioning of RTA, but not holoricin, in the detergent phase after Triton-X114 extraction, and the spontaneous structural changes that occur in RTA in the presence of negatively charged phospholipids Mayerhofer et al. 2009 ). Furthermore, when RTA is tagged with fluorophores in different positions around the molecule, some fluorophore tags are quenched in the presence of microsomal membranes pre-soaked with a lipopholic quencher, whilst fluorophores in other positions are not. Thus the interaction with lipid membranes is not random -some parts of the RTA molecule are excluded from the lipid bilayer, whilst at least two amino acids in the hydrophobic Cterminal patch of RTA (Cys259 and I249) enter the non-polar core of a lipid membrane (Mayerhofer et al. 2009 ). Insertion into the membrane is temperaturedependent: at low temperatures, RTA binds membranes, and as the temperature increases, structural changes associated with membrane entry become more apparent (Mayerhofer et al. 2009 ). Isolated purified RTA is temperature-sensitive, forming a molten globule at 45ºC (Argent et al. 2000) , but even at 37 ºC, it is relatively unstable, and prone to aggregation (Spooner et al. 2008a ).
The driving force for RTA unfolding thus appears to be thermal instability of RTA released from holotoxin coupled with an ordered insertion into the membrane that results in a remodelling of RTA structure. This membrane-embedded form is thought to mimic a misfolded protein that is then dislocated from the ER in an ERAD-like manner.
The A1 chain of STx also possesses a relatively hydrophobic string of amino-acids, which is required for the dislocation of the A1 chain expressed in the yeast ER (LaPointe et al. 2005) . Furthermore, an artificial peptide based on this sequence interacts with lipid membranes (Menikh et al. 1997; Saleh et al. 1996) . Whilst the parellels with RTA structure might seem obvious, we note that this region is already substantially exposed in the holotoxin (Figure 4, blue) , and it remains to be determined whether membrane interactions induce conformational changes in SLTxA1 that are then recognized by the dislocation machinery.
An examination of the CTxA1 chain shows no obvious candidates for a hydrophobic region exposed after subunit separation that may act to destabilise A1 structure by interacting with lipid membranes. Instead, an overt role for PDI in the unfolding of the A1 chain has been proposed, since in the presence of reduced PDI, the CTxA1 chain becomes markedly trypsin sensitive (Tsai et al. 2001) . Another member of the PDI family, ERp72, plays an ER retention role for CTxA, stabilising its structure in a trypsin-resistant form (Forster et al. 2006 ). An alternative model suggests that unfolding of CTxA occurs because it is, like RTA, thermally unstable after release from holotoxin (Pande et al. 2007) , with a protease-sensitive structure at 37ºC that is not apparent in the holotoxin. Thermal instability in the dissociated CTxA1 chain could thus allow it to mimic a misfolded protein for ERAD-like export to the cytosol.
Consistent with this, in vivo stabilisation of the structure of CTxA1 with glycerol reduces cholera toxicity by inhibiting dislocation (Massey et al. 2009 ). Furthermore, dissection of the process of unfolding reveals subdomains of A1 that are temperaturesensitive and those that serve to stabilise A1 structure, studies that may lead to a full mechanistic description of the unfolding process (Banerjee et al. 2010 ).
4.3
Maintenance of Solubility and Recognition as Substrates for ER-cytosol
Dislocation
Hydrophobic regions on otherwise soluble proteins provide motifs for recognition by ER chaperones such as the Hsc70 family chaperone BiP, which maintain solubility of these substrates . The initial remodelling of RTA after subunit reduction may therefore explain why, when expressed in the yeast ER, maximal toxicity of RTA requires the co-chaperones of Kar2p, the yeast equivalent of BiP (Li et al. 2010 ) and rationalise a proposed role for the Hsp90 family ER chaperone GRP94 in ricin toxicity to mammalian cells (Spooner et al. 2008a; Taylor et al. 2010 ).
The process of recognition of an ERAD substrate is currently an active area of research, using only a few known model substrates. For example, specific N-glycans appear to act as folding sensors that can recognise altered protein stabililty ( When expressed in the yeast ER, RTA dislocation is preceded by engagement with a specific COPII-interacting ER transmembrane p24 protein, leading to possible Golgi trafficking and subsequent return to the ER (Li et al. 2010 ). This may be a universal requirement for ricin toxicity, since partial screening of an RNAi library in Drosophila melanogaster S2 cells for sensitivity changes to ricin challenge also identifies the fly equivalent of Erp2p and its interacting proteins as important in ricin toxicity (Pawar et al. 2011 ). Furthermore, in mammalian cells, ricin cytotoxicity is perturbed by interfering with Rab1 and Sar1, which control ER to Golgi trafficking (Simpson et al. 1995a) , again suggesting a requirement for RTA to enter the Golgi from the ER. Thus recognition of RTA as a misfolded substrate for dislocation may not occur in the ER lumen, but perhaps in the Golgi or at least in the context of proteins that associate with COPII coated buds. The final recognition of misfolded RTA as a dislocatable substrate appears to be by membrane-integral components of the HRD ubiquitin ligase complex that probably forms the dislocon.
For STx, the hydrophobic stretch in the A1 subunit is already substantially exposed in the holotoxin (Figure 3, blue) , so the strong interactions of STxA with a preassembled ER luminal protein complex containing the chaperones HEDJ, BiP and GRP94 associated with the Sec61 translocon core unit (Falguieres and Johannes 2006; Yu and Haslam 2005) may also be initiated with the holotoxin. BiP is also thought to maintain the solubility of CTxA1 (Winkeler et al. 2003) .
Dislocation across the ER Membrane
Currently, the RTA dislocation process is largely uncharacterised in mammalian cells:
little is known beyond the implication of Sec61 as part of a dislocation channel (Simpson et al. 1999; Slominska-Wojewodzka et al. 2006; Wesche et al. 1999 ) and
the lack of obvious function of derlins (Slominska-Wojewodzka et al. 2006 ).
However, when expressed exogenously in the yeast ER lumen RTA dislocates and folds to an active conformation in the cytosol, reducing yeast protein synthesis activity and causing a severe growth defect (Li et al. 2010 ). This has allowed us to examine the requirements for RTA dislocation ( Figure 5) .
RTA utilises the integral membrane protein HRD E3 ubiquitin ligase complex for dislocation. This comprises the multi-spanning Hrd1p ubiquitin ligase which may constitute the central core of a dislocon (Gauss et al. 2006) , the Hrd3p protein that is required for maintenance of Hrd1p (Gardner et al. 2000) and Usa1p, which promotes optimal Hrd1p activity (Carroll and Hampton 2010) . This complex recognises misfolded membrane spanning domains, but has a modular design (Kanehara et al. 2010 ), allowing add-on functions such as those provided by Der1p and Usa1p, which adapt the complex for recognition of misfolded luminal domains (Carvalho et al. 2006) , and provision for engagement via Hrd3p of proteins such as Yos9p involved in N-glycan surveillance (Denic et al. 2006) . It is anchored at the dislocation site by the membrane-integral Cue1p which recruits (Biederer et al. 1997 ) and activates (Bazirgan and Hampton 2008) the ubiquitin-conjugating E2 Ubc7p. RTA has relatively minor requirements for Usa1p, Cue1p and Ubx7p and shows no requirements for Yos9p functions. Furthermore, RTA dislocation is independent of the E3 activity of Hrd1p (Li et al. 2010) . ER dislocation of RTA in plant cells is also independent of canonical ubiquitylation (Marshall et al. 2008) . Consistent with the lack of dislocation-associated polyubiquitylation, RTA is not extracted from the yeast ER by Cdc48p or its ubiquitin-handling co-factors (Li et al. 2010) . Instead the extraction motor appears to be the Rpt4p subunit of the proteasomal cap, which had previously been shown to play a role in extraction of other substrates in conjunction with Cdc48p (Lipson et al. 2008) . Finally, dislocated RTA is not degraded by the proteasomal core (Li et al. 2010) .
Thus RTA appears to be dislocated promiscuously through non-anchored, nonoptimised dislocons in a manner that either displaces the RING-H2 ubiquitin ligase domain of Hrd1p or avoids it altogether, and newly-dislocated RTA avoids proteasomal destruction. In marked contrast ( Figure 5 ), a mutated form of RTA that is unable to fold to an active conformation acts as a bona-fide ubiquitylated and Nglycosylated ERAD substrate that is extracted in a Cdc48p-dependent manner, deglycosylated by Png1p, passed to the proteasome by Rad21p and is then degraded by the proteasomal core (Li et al. 2010) .
For STxA1 for the dislocation of its own A1 chain. CTx binds both gp78 and Hrd1 and since these are E3 ubiquitin ligases, a role for ubiquitin in dislocation has been proposed (Bernardi et al. 2010 ). However, like RTA, wild-type CTxA dislocates in a manner independent of canonical ubiquitylation (Rodighiero et al. 2002) and N-terminal extension of CTxA results in its conversion to an ERAD substrate by displacing the two lysyl residues normally near the N terminus, making them substrates for dislocation-associated polyubiquitylation (Wernick et al. 2010 ). An initial view that Derlin-1 is required for CTxA1 dislocation (Bernardi et al. 2008 ) has been reversed after taking into account the effect of manipulating Derlin-1 levels in the absence of CTx challenge (Saslowsky et al. 2010) . Whether ER extraction requires the mammalian equivalent of Cdc48p, p97 (Abujarour et al. 2005) or not (Kothe et al. 2005 ) is unclear, although down-regulation of Ufd1 and Npl4, co-factors of p97, appears to sensitise cells to cholera toxin challenge (McConnell et al. 2007) . A role for the cytosolic chaperone Hsp90 has also been proposed for the dislocation of CTxA, since in the presence of an Hsp90 inhibitor, there is little if any CTxA chain found in the cytosol ).
Dislocation of A chains might be expected to leave an excess of B chains
accumulating in the ER. However, when RTB is expressed exogenously in the mammalian ER, it is trapped for a while by a thiol anchor, and then disappears from the ER by two mechanisms: approximately half is secreted, whilst the remainder becomes an ERAD substrate that can be stabilised by proteasomal inhibition (Spooner et al. 2004 ). The fates of STxB/A2 and CTxB/A2 are currently unmapped.
6
Cytosolic Post-dislocation Events that Restore Catalytic Activity
The protein toxins are thought to enter the cytosol in a substantially disordered conformation, so recovery of catalytic activity is expected to require extensive folding in the cytosol.
In vitro, RTA carefully unfolded to a molten globule structure can recover catalytic activity in the presence of substrate ribosomes (Argent et al. 2000) . In vivo, though, in mammalian cells postdislocation scrutiny by the cytosolic chaperone Hsc70 (Figure 6) is required for RTA to gain a catalytic conformation (Spooner et al. 2008a) , followed by specific depurination of the ribosomal targets ) and subsequent cell death. Since Hsc70 in vitro can prevent aggregation of heat denatured RTA, one in vivo role may be to aid solubility of dislocated RTA, so that it can then undergo substrate-mediated refolding. Alternatively, the role of Hsc70 may be to stabilise RTA in the cytosol by masking the hydrophobic patch that interacts with membranes.
The ability of Hsc70 to aid RTA activation depends on the prevailing concentrations of Hsc70 co-chaperones, with some (HIP and BAG-2) promoting folding of RTA, and others such as the proteasome-engaging BAG-1 promoting inactivation. In addition, there is a sequential chaperone triage in the cytosol, where a proportion of RTA is passed, via the Hsc70-Hsp90 organising protein HOP, to the Hsp90 chaperone. From here, the net fate of RTA is inactivation. Although RTA is not ubiquitylated during dislocation, a low level of cytosolic ubiquitylation of RTA does occur via an unknown E3 ligase (Li et al. 2010) . In vitro, RTA can be ubiquitylated very inefficiently in the presence of Hsc70 and the cytosolic CHIP E3 ubiquitin ligase, and this can be improved by mimicking the sequential triage by adding the co-chaperone HOP and the heat shock chaperone Hsp90, suggesting that Hsp90 interactions inactivate RTA by promoting cytosolic ubiquitylation (Spooner et al. 2008a) . Thus a network of chaperones determines RTA fate in the cytosol by regulating the competing processes of folding and ubiquitin-tagging. This may provide a rationale for why inhibition of proteasomal degradation sensitises cells slightly to intoxication by a toxin that is not ubiquitylated during dislocation (Deeks et al. 2002; Wesche et al. 1999) .
For STx, inhibition of proteasomal degradation has been reported to give a slight increase in cytotoxicity of the toxin, of the same order of magnitude as that of sensitisation to ricin (Tam and Lingwood 2007) , suggesting that there is a role for ubiquitin tagging in the fate of cytosolic STx. Thermally-unfolded CTxA can be degraded in a ubiquitin-independent fashion by the 20S core proteasome (Pande et al. 2007 ), so CTxA1 survival in the cytosol was thought to require rapid spontaneous folding (Rodighiero et al. 2002) allowing proteasomal avoidance. Structural studies, though, suggest that a likely route of toxin activation is via substrate-mediated folding in the cytosol with ARF6 stimulating the refolding of the C-terminus of CTx (Ampapathi et al. 2008 ). In addition, the requirement for Hsp90 for CTx toxicity ) may also reflect cytosolic post-dislocation events where Hsp90 is required for maintenance of CTxA1 in the cytosol, protecting the toxin from proteasomal degradation.
Concluding Remarks
From early observations that the toxic polypeptides of ER-trafficking toxins have low lysine content, and so might avoid canonical ubiquitylation and subsequent proteasomal degradation (Hazes and Read 1997) , through trafficking studies that demonstrated ER arrival of holotoxin, to molecular dissection of pre-dislocation, dislocation and post-dislocation events, the notion that these toxic subunits dislocate in an ERAD-like manner has been validated, particularly for RTA.
RTA is not ubiquitylated by Hrd1p during dislocation (Li et al. 2010 ) but augmenting its lysyl content results in conversion to an ERAD substrate and subsequent proteasomal destruction (Deeks et al. 2002) . Similarly CTxA1 dislocates in a manner independent of canonical ubiquitylation (Rodighiero et al. 2002) , although appending a N-terminal extension permits two lysyl residues to become ubiquitylated, converting
CTxA1 into a bona-fide ERAD substrate (Wernick et al. 2010 ). Thus, dislocation and refolding of the wild-type toxic polypeptides must proceed in a way that protects canonical sites for ubiquitylation from the Hrd1 ubiquitin ligase activity. These toxin subunits may displace the RING-H2 domain of Hrd1. Alternatively, RTA and CTx1 may normally dislocate with a partially structured conformation that hinders access of the RING-H2 domain to these sites. Since these proteins gain catalytic activity in the cytosol, the fate of a Hrd1-dislocated protein is not necessarily destruction, and so ERAD is simply a sub-set (albeit the most studied) of ER-cytosol dislocation events.
Furthermore, dislocation of RTA does not require a fully-functional or anchored dislocon, supporting the notion that there is a core dislocon that is adaptable by addition of bolt-on functions (Kanehara et al. 2010) .
The key to uncoupling from the final destructive stage of ERAD, for at least the two dislocating proteins RTA and CTxA1, is avoidance of polyubiquitylation via the membrane-integral E3 ligase Hrd1. In turn this permits bypass of Cdc48/p97
interactions for cytosolic extraction and subsequent proteasomal presentation, at least for RTA. Instead RTA utilises the proteasomal cap subunit Rpt4p (Li et al. 2010) , which can also provide a driving force for substrate extraction from the ER (Lipson et al. 2008) . Similarly, the K28 viral killer toxin dislocates without being ubiquitylated and without assistance from Cdc48p and its Npl4p and Ufd1p co-factors, and is not degraded by the proteasomal core (Heiligenstein et al. 2006) . These studies raise the question of whether or not such avoidance of Cdc48p/p97 interactions is universal for those other proteins, such as luciferases and calreticulin, which can dislocate from the ER to gain function in the cytosol. STxA2, orange. The hydrophobic stretch (blue) is largely exposed in the holotoxin. Prior to dislocation there is a compulsory interaction of RTA with a COPII associated p24 protein (Erp2p) that may point to a requirement for ER-Golgi transport for recognition or retrieval of misfolded RTA. 2. Dislocation requires the core components of the Hrd1p-Hrd3p dislocaon, but not the Hrd1p E3 ubiquitin ligase activity encoded by its RING-H2 domain (H2). The requirements for der1p, Usa1p, Cue1p and Ubc7p are intermediate and for Ubx2p, the requirement is minor. 3.
Figure legends
Extraction of RTA from the dislocon requires the Rpt4p subunit of the proteasome cap. 4. In contrast, the mutant RTA Δ that is unable to fold to a catalytic conformationis a bona-fide ERAD substrate that is ubiquitylated by Hrd1p and extracted by the Cdc48 complex, deglycosylated by Png1p and requires the proteasomal receptor Rad23p and the proteasomal cap unit Rpt2 which provides access to the proteolytic activities of the proteasome core. 
